Medical News

RSS

Aeroneb drug delivery products receive marketing authorisation in China

Aerogen,the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China.

17 Feb 2012

HMS fourth quarter revenue increases 14.3% to $99.7 million

HMS Holdings Corp. today announced financial results for its fourth quarter and full year ended December 31, 2011.

17 Feb 2012

Atomoxetine drug may restore memory deficits in menopausal women

Memory lapses and changes in mental functions occur naturally as we get older. But for many women going through menopause, these memory lapses occur more frequently.

17 Feb 2012

Asuragen introduces miRInform test for diagnosis of pancreatic ductal adenocarcinoma

Asuragen, Inc. announced today the immediate availability of the miRInform® Pancreas Test in its CAP-accredited CLIA Laboratory. miRInform® Pancreas was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive. The test evaluates expression levels of seven miRNAs in Fine Needle Aspirate (FNA) specimens of pancreatic masses.

17 Feb 2012

Abcodia, Volition announce collaboration agreement

VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces a collaboration agreement with Abcodia, a specialist company spun out from University College London (UCL), under which Volition will gain access to Abcodia's biobank of over 5,000,000 human serum samples to validate its suite of NuQ tests.

17 Feb 2012

Innocoll completes XaraColl End-of-Phase 2 meeting with FDA

Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair.

17 Feb 2012

Scientists discover molecular pathway by which maternally inherited deafness appears to occur

Yale scientists have discovered the molecular pathway by which maternally inherited deafness appears to occur: Mitochondrial DNA mutations trigger a signaling cascade, resulting in programmed cell death.

17 Feb 2012

Pharmos reports net loss of $0.4 million for fourth quarter 2011

Pharmos Corporation reported financial results for the fourth quarter and twelve-month period ended December 31, 2011. These results are included in the Company's Yearly Report on Form 10-K which has been filed with the SEC.

17 Feb 2012

New technology opens up pathways for disease cures

The understanding of diseases such as Parkinson's and Alzheimer's is set to take a step forward following groundbreaking technology at which will enable cell analysis using automated 3D microscopy.

17 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

CryoPort announces closure of $5.0M private placement

CryoPort, Inc. today announced it has closed a private placement with various accredited investors for gross proceeds of $5.0 million. The Company obtained agreements to purchase 9,119,100 shares of common stock at $0.55 per share.

17 Feb 2012

BYETTA-basal insulin combination therapy receives EMA CHMP positive opinion

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.

17 Feb 2012

Greatbatch acquires NeuroNexus

Greatbatch, Inc., today announced the acquisition of NeuroNexus Technologies for approximately $12 million in cash, including the assumption of debt and future considerations.

17 Feb 2012

State roundup: U.S. Senators demand more medical board oversight; Californians losing coverage; Arizona's prison 'quandary'

"The administration never consulted us," said Susan Millerick, spokeswoman for the Hartford-based Aetna. Other Connecticut health insurers are letting the American Health Insurance Plans, a Washington-based trade association, voice their concerns. ... "We are concerned about the precedent this proposed rule would set," AHIP spokesman Robert Zirkelbach said.

17 Feb 2012

Good surveillance system for FMD can minimize economic losses to Mexican cattle industry

In a worst-case scenario simulation of a foot-and-mouth disease outbreak in Mexico, researchers found that establishing a good surveillance system and raising a more resilient breed of cattle could lessen the blow to the Mexican cattle industry should an outbreak of foot-and-mouth disease (FMD) or other infectious disease occur.

17 Feb 2012

Digital games become an important tool for self-management of illness and chronic conditions

Millions of dollars and immeasurable hours of research and development are being invested to develop and employ increasingly sophisticated hardware and software technologies to deliver innovative new personalized health care interventions.

17 Feb 2012

CPALMS educator platform to expand with $10.5M grant

Between teaching, paperwork, assessments, discipline and grading, schoolteachers have a demanding job, and lately it's becoming even tougher.

17 Feb 2012

Standardization may improve Canada's ranking in international child health indexes

Canada's ranking in international child health indexes would dramatically improve if measurements were standardized, according to a new study by researchers from the University of British Columbia, Dalhousie University, McGill University, the University of Calgary, and the Public Health Agency of Canada, working with the Canadian Perinatal Surveillance System and funded by the Canadian Institutes of Health Research (CIHR).

17 Feb 2012

Another short-term 'patch' to Medicare physician payment crisis disappoints

Our organizations, representing nearly 400,000 physicians and medical student members, are deeply disappointed by the agreement in Congress to enact another short-term "patch" that neither solves, nor moves us closer to solving, the Medicare physician payment crisis.

17 Feb 2012

Congressional negotiators announce 'doc fix,' payroll tax cut deal

Some Democrats fretted over cuts to the health care law to help pay for the package; physician groups were disappointed it did not replace Medicare's sustainable growth rate formula.

17 Feb 2012